SION Sionna Therapeutics, Inc.

Fundamentals / CIK 0002036042 / USD

Sionna Therapeutics, Inc. reported $263.3M in total assets and a net loss of $109.5M through December 31, 2025 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open SION in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

2 fiscal years (2024 to 2025), reported in USD.

$0$0$0-$70.38MFY 2024 Net Income: -$61.69M2024FY 2025 Net Income: -$75.27M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31
Research & Development $60.26M $57.29M
Total Operating Expenses $88.98M $70.56M
Operating Income -$88.98M -$70.56M
EBITDA -$88.33M -$69.89M
Interest Income $13.29M $8.17M
Income Tax Expense $0 $0
Net Income -$75.27M -$61.69M
Basic EPS -$1.88 -$15.99
Diluted EPS -$1.88 -$15.99
Basic Shares Outstanding 40.0M 3.9M
Diluted Shares Outstanding 40.0M 3.9M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Research & Development $22.02M $21.86M $18.96M $15.17M $16.04M $15.38M $13.67M $14.25M
Total Operating Expenses $34.82M $32.47M $29.60M $23.61M $23.80M $21.91M $19.66M $18.13M
Operating Income -$34.82M -$32.47M -$29.60M -$23.61M -$23.80M -$21.91M -$19.66M -$18.13M
EBITDA -$34.62M -$32.27M -$29.45M -$23.46M -$23.70M -$21.81M -$19.50M -$17.97M
Interest Income $2.41M $2.59M $2.82M $3.17M $3.46M $3.67M $3.00M $2.12M
Net Income -$32.42M -$29.89M -$26.78M -$20.44M -$20.28M -$18.07M -$16.48M -$15.85M
Basic EPS -$0.72 -$0.66 -$0.60 -- -$0.46 -$0.41 -$0.62 --
Diluted EPS -$0.72 -$0.66 -$0.60 -- -$0.46 -$0.41 -$0.62 --
Basic Shares Outstanding 45.2M 45.1M 44.9M -- 44.3M 44.1M 26.6M --
Diluted Shares Outstanding 45.2M 45.1M 44.9M -- 44.3M 44.1M 26.6M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31
Cash & Cash Equivalents $58.45M $37.79M
Cash & Short-Term Investments $58.45M $37.79M
Total Current Assets $241.4M $151.0M
Property, Plant & Equipment, Net $2.23M $2.47M
Other Non-Current Assets $0 $2.99M
Total Non-Current Assets $84.53M $34.76M
Total Assets $326.0M $185.8M
Accounts Payable $769K $1.19M
Other Current Liabilities $6.0K $0
Total Current Liabilities $11.71M $10.42M
Total Non-Current Liabilities $7.41M $8.68M
Total Liabilities $19.12M $19.10M
Total Debt (incl. Leases) $8.68M $9.75M
Common Stock $45K $5.0K
Retained Earnings -$256.4M -$181.1M
Accumulated Other Comp. Income $540K $368K
Total Stockholders' Equity $306.8M -$163.7M
Total Equity $306.8M -$163.7M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $83.88M $63.32M $63.32M $58.45M $50.83M $40.98M $82.69M $37.79M
Cash & Short-Term Investments $249.8M $268.3M $289.9M $58.45M $325.0M $337.3M $354.7M $37.79M
Total Current Assets $228.5M $216.1M $221.0M $241.4M $252.3M $266.7M $273.7M $151.0M
Property, Plant & Equipment, Net $1.76M $1.92M $2.07M $2.23M $2.14M $2.25M $2.39M $2.47M
Other Non-Current Assets $638K $594K $585K $0 $0 $0 $0 $2.99M
Total Non-Current Assets $34.73M $67.12M $84.08M $84.53M $86.94M $85.30M $95.99M $34.76M
Total Assets $263.3M $283.2M $305.0M $326.0M $339.3M $352.0M $369.7M $185.8M
Accounts Payable $1.05M $523K $2.11M $769K $1.48M $914K $5.02M $1.19M
Other Current Liabilities $0 $7.0K $17K $6.0K $224K -- -- $0
Total Current Liabilities $16.42M $10.78M $9.78M $11.71M $9.85M $7.55M $9.53M $10.42M
Total Non-Current Liabilities $6.32M $6.69M $7.05M $7.41M $7.75M $8.07M $8.38M $8.68M
Total Liabilities $22.74M $17.47M $16.83M $19.12M $17.60M $15.62M $17.91M $19.10M
Total Debt (incl. Leases) $7.75M $8.07M $8.38M $8.68M $8.97M $9.24M $9.50M $9.75M
Common Stock $45K $45K $45K $45K $44K $44K $44K $5.0K
Retained Earnings -$345.4M -$313.0M -$283.1M -$256.4M -$235.9M -$215.6M -$197.6M -$181.1M
Accumulated Other Comp. Income -$723K -$448K -$84K $540K $420K $183K $301K $368K
Total Stockholders' Equity $240.5M $265.8M $288.2M $306.8M $321.7M $336.4M $351.8M -$163.7M
Total Equity $240.5M $265.8M $288.2M $306.8M $321.7M $336.4M $351.8M -$163.7M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31
Net Income -$75.27M -$61.69M
Depreciation & Amortization $647K $668K
Stock-Based Compensation $12.07M $3.71M
Change in Payables -$417K $467K
Operating Cash Flow -$66.30M -$52.79M
Capital Expenditure -$377K -$27K
Free Cash Flow -$66.67M -$52.81M
Purchases of Investments -$325.0M -$182.8M
Investing Cash Flow -$118.7M -$126.9M
Financing Cash Flow $205.7M $179.0M
Net Change in Cash $20.66M -$733K

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$32.42M -$29.89M -$26.78M -$20.44M -$20.28M -$18.07M -$16.48M -$15.85M
Depreciation & Amortization $200K $200K $154K $152K $100K $100K $159K $167K
Stock-Based Compensation $7.08M $6.84M $6.55M $3.83M $3.31M $2.84M $2.09M $1.06M
Change in Payables $604K -$1.53M $1.21M -$712K $567K -$3.83M $3.55M $1.08M
Operating Cash Flow -$18.72M -$22.22M -$21.84M -$16.63M -$15.23M -$18.15M -$16.29M -$11.78M
Capital Expenditure $0 $0 $0 -$204K -$87K $0 -$86K -$27K
Free Cash Flow -$18.72M -$22.22M -$21.84M -$16.83M -$15.32M -$18.15M -$16.37M -$11.81M
Purchases of Investments -$11.35M -$33.03M -$25.33M -$42.88M -$54.14M -$56.42M -$171.6M -$7.20M
Investing Cash Flow $38.95M $21.47M $24.82M $22.59M $23.10M -$23.25M -$141.2M $15.23M
Financing Cash Flow $333K $749K $1.89M $1.66M $1.97M -$312K $202.4M -$1.41M
Net Change in Cash $20.56M -$2.0K $4.87M $7.62M $9.85M -$41.71M $44.91M $2.04M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31
Return on Equity (ROE) -24.5% --
Return on Assets (ROA) -23.1% -33.2%
Current Ratio 20.61x 14.49x
Quick Ratio 4.99x 3.63x
Debt to Equity 0.03x --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Return on Equity (ROE) -45.5% -36.6% -29.7% -24.5% -22.0% -22.5% -18.9% --
Return on Assets (ROA) -41.6% -34.4% -28.1% -23.1% -20.8% -21.5% -17.9% -33.2%
Current Ratio 13.92x 20.05x 22.60x 20.61x 25.61x 35.33x 28.73x 14.49x
Quick Ratio 15.21x 24.88x 29.65x 4.99x 32.99x 44.68x 37.23x 3.63x
Debt to Equity 0.03x 0.03x 0.03x 0.03x 0.03x 0.03x 0.03x --
Source: SEC EDGAR CompanyFacts (CIK 0002036042) · from March 31, 2024 Data through September 30, 2026 · synced Nov 20, 2026, 05:46 UTC · Open in terminal